Literature DB >> 8384436

Effect of diabetes mellitus on hepatic resection.

K Yanaga1, T Matsumata, H Hayashi, M Shimada, K Urata, T Suehiro, K Sugimachi.   

Abstract

We evaluated the effect of diabetes mellitus on mortality and morbidity after elective hepatic resections. Of 209 patients who underwent hepatic resections between April 1985 and July 1990, 49 (23.4%) were diabetic. Postoperative morbidity was more common among diabetics than among nondiabetics (75.5% vs 51.3%), mainly due to hepatic decompensation (55.1% vs 36.3%) and intraperitoneal sepsis (18.4% vs 6.3%). However, their incidence of hospital death (2% vs 2.5%), mean +/- SD postoperative hospital stay (36.1 +/- 20.2 days vs 29.4 +/- 28.2 days), and long-term survival were comparable with those of nondiabetics. Diabetics with and without complications were similar in preoperative or postoperative insulin requirement, duration of diabetes, and preoperative fasting glucose. Nevertheless, all eight patients with 24-hour urinary glucose excretion above 1 g developed complications. We conclude that diabetics are at a high risk of morbidity, but not of mortality after elective hepatic resection.

Entities:  

Mesh:

Year:  1993        PMID: 8384436     DOI: 10.1001/archsurg.1993.01420160087014

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

1.  Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort study.

Authors:  Zhe-Wei Wei; Jia-Ling Li; Ying Wu; Guang-Kai Xia; Roderich E Schwarz; Yu-Long He; Chang-Hua Zhang
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

2.  Long-term comorbidity of diabetes mellitus is a risk factor for perineal wound complications after an abdominoperineal resection.

Authors:  Kenji Matsuda; Tsukasa Hotta; Katsunari Takifuji; Shozo Yokoyama; Takashi Higashiguchi; Toshiji Tominaga; Yoshimasa Oku; Toru Nasu; Koichi Tamura; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2008-07-08       Impact factor: 3.445

3.  Influence of metabolic and other clinicopathologic factors on the prognosis of patients with hepatocellular carcinoma undergoing hepatic resection.

Authors:  Kui Sun Choi; Dong-Sik Kim; Sung Won Jung; Young-Dong Yu; Sung Ock Suh
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-11-30

Review 4.  Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Yan-Gang Wang; Peng Wang; Bin Wang; Zheng-Ju Fu; Wen-Juan Zhao; Sheng-Li Yan
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

5.  Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy.

Authors:  Yan-Yan Wang; Shan Huang; Jian-Hong Zhong; Yang Ke; Zhe Guo; Jia-Qi Liu; Liang Ma; Hang Li; Bing-Ning Ou; Le-Qun Li
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

6.  Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis.

Authors:  Qingshan Li; Yue Wang; Tao Ma; Yi Lv; Rongqian Wu
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

7.  An Elevated HbA1c Level Is Associated With Short-Term Adverse Outcomes in Patients With Gastrointestinal Cancer and Type 2 Diabetes Mellitus.

Authors:  Yingchun Huang; Huazhen Zheng; Peicong Chen; Jin Yang; Shaomin Lin; Tingting Liu; Shanwei Chen; Siqiang Lu; Junlian Chen; Wenpu Chen; Nanhai Peng
Journal:  J Clin Med Res       Date:  2017-02-21

8.  Preexisting Diabetes and Risks of Morbidity and Mortality After Gastrectomy for Gastric Cancer: A Nationwide Database Study.

Authors:  Ming-Shian Tsai; Yu-Chiao Wang; Yin-Hsien Kao; Long-Bin Jeng; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.